Monday, September 25, 2017
 
 
Company News: Page (1) of 1 - 09/06/17 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
PDI Healthcare Hosts Educational Session at AVA 2017 on CHG's Role in CLABSI Prevention
PDI's Prevantics® Device Swab Highlighted in Poster Presentation
(September 06, 2017)

ORANGEBURG, N.Y., Sept. 6, 2017 /PRNewswire/ -- PDI, a leader in infection prevention products and solutions, today announced it will host an educational session focused on the role of chlorhexidine gluconate (CHG) in central line-associated bloodstream infection (CLABSI) prevention at the 2017 Annual Scientific Meeting of the Association for Vascular Access. The meeting, which will take place at the Phoenix Convention Center in Phoenix, Arizona from Sept. 16-19, will also feature PDI's Prevantics® Device Swab as the subject of a poster presentation highlighting positive impacts and improved CLABSI outcomes at a healthcare facility.

PDI logo (PRNewsFoto/PDI)

On Sept. 18 from 5:15 to 6:15 p.m., infection prevention expert Joan Hebden, MS, RN, CIC, FAPIC will present a session titled "Chlorhexidine Gluconate: The 'It' Antiseptic?". The session will define CHG's mechanism of action, as well as the mechanism for development of CHG resistance. Attendees will understand the two modes of bacterial pathogenesis into the bloodstream from intravascular device, and review the current CDC recommendations for the use of CHG to prevent CLABSIs.


Additionally, a Virginia-based healthcare facility is presenting a poster that features PDI's Prevantics Device Swab. After experiencing an increase in CLABSI rates, the facility sought an effective way to improve disinfection compliance before every intravenous access. After Prevantics Device Swab was implemented hospital-wide in January 2016, CLABSIs decreased 76% year-over-year, from 17 documented infections in 2015 to four in 2016. The poster concludes that the introduction of the Prevantics Device Swab increases compliance, provides fast and effective disinfection, decreases infections and ultimately improves patient outcomes. The full poster can be viewed online here.

In exhibitor booth #425, PDI also will showcase several marquee products in a simulated hospital room, utilizing a mannequin in a dialysis chair to demonstrate how to:

  • Perform proper hand hygiene with PDI's Sani-Hands® Antimicrobial Wipes
  • Prep skin with PDI's Prevantics® Skin antiseptics
  • Disinfect devices with PDI's Prevantics® Device Swab

About PDI Healthcare
PDI offers a broad range of evidence-based, market-leading Interventional Care, Environment of Care, and Patient Care solutions, all designed to help reduce preventable infections, control healthcare costs, and ultimately help save lives. It's all part of PDI's passion to Be The Difference®, every day. To learn more, visit pdihc.com.  

Media Contact:
Lindsey Schmidt
Kwittken
212-352-6537
[email protected]

View original content with multimedia:http://www.prnewswire.com/news-releases/pdi-healthcare-hosts-educational-session-at-ava-2017-on-chgs-role-in-clabsi-prevention-300514474.html

SOURCE PDI Healthcare

Copyright 2014 PR Newswire. All Rights Reserved


Page: 1


Related Keywords:Medical Professionals,
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter
 
 
 
 
 
Seniors

Drugs
  • The High-Tech Future of Home Healthcare
  • A Medical Implants Manufacturer Used Salesforce Effectiveness Solution to Improve Salesforce Performance Provided by Quantzig
  • Point of Care Technology Market :Company information, geographical data and Market Analysis
  • Dental Market Trends, Size, Growth, Leading Players, Opportunities and 2021 Global Analysis Forecasts Discussed in New Research Report
  • Human Genetics Market Dynamics, Comprehensive Analysis, Business Growth, Prospects and Opportunities 2016-2024

    Cancer
  • Targovax granted US Patent for mutant-RAS neoantigen platform lead products
  • Hammertoe Market US $ 450 Million Acquire A Massive Growth By 2023
  • Hammertoe Market US $ 450 Million Acquire A Massive Growth By 2023
  • Crux Quality Solutions To Exhibit And Demo Workflow Automation Tool, FlowBoard At ASTRO 2017 Annual Meeting
  • Elekta and Brainlab Collaborate to Streamline Treatment Workflows for Stereotactic Radiation Therapy
  •  
     
     
     
     
     





    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines